Robbins Farley Sells 775 Shares of CVS Health Co. (NYSE:CVS)

Robbins Farley trimmed its holdings in shares of CVS Health Co. (NYSE:CVS) by 27.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,000 shares of the pharmacy operator’s stock after selling 775 shares during the period. Robbins Farley’s holdings in CVS Health were worth $136,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Stonebridge Financial Group LLC bought a new stake in CVS Health in the fourth quarter valued at approximately $28,000. Hopwood Financial Services Inc. bought a new stake in CVS Health in the fourth quarter valued at approximately $29,000. McIlrath & Eck LLC increased its stake in CVS Health by 32.6% in the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 174 shares in the last quarter. MV Capital Management Inc. boosted its holdings in shares of CVS Health by 63.9% in the first quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator’s stock valued at $50,000 after buying an additional 289 shares during the period. Finally, Financial Perspectives Inc boosted its holdings in shares of CVS Health by 137.5% in the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator’s stock valued at $36,000 after buying an additional 466 shares during the period. 80.66% of the stock is owned by institutional investors.

Insider Activity

In related news, Director Guy P. Sansone acquired 1,570 shares of the company’s stock in a transaction dated Thursday, June 5th. The shares were bought at an average cost of $63.70 per share, with a total value of $100,009.00. Following the completion of the transaction, the director now directly owns 12,007 shares of the company’s stock, valued at $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 1.22% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on CVS shares. Wall Street Zen upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Cowen reiterated a “buy” rating on shares of CVS Health in a report on Monday, May 5th. Mizuho upped their price target on shares of CVS Health from $70.00 to $76.00 and gave the company an “outperform” rating in a report on Wednesday, April 9th. Royal Bank of Canada upped their price target on shares of CVS Health from $74.00 to $81.00 and gave the company an “outperform” rating in a report on Monday, May 5th. Finally, Robert W. Baird upped their price target on shares of CVS Health from $51.00 to $71.00 and gave the company a “neutral” rating in a report on Tuesday, April 15th. Two research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $74.75.

CVS Health Stock Performance

Shares of CVS stock opened at $67.42 on Friday. The stock has a market cap of $85.29 billion, a P/E ratio of 18.42, a P/E/G ratio of 0.98 and a beta of 0.56. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The company has a fifty day moving average price of $65.15 and a two-hundred day moving average price of $60.15. CVS Health Co. has a one year low of $43.56 and a one year high of $72.51.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.63. The company had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The company’s revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.31 earnings per share. As a group, equities analysts predict that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.95%. The ex-dividend date was Tuesday, April 22nd. CVS Health’s payout ratio is presently 63.48%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.